CIK: 0001560009
Total reported value
$141.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 44.16% | -0.16% | -0.54% | |
| 2 | ADVMCHF | Adverum Biotechnologies INC | Stock-Other | 21.01% | — | -0.91% | |
| 3 | ✓ | Stock-Other | 10.33% | — | — | ||
| 4 | AKRO | Akero Therapeutics INC | Stock-Other | 7.57% | — | -22.70% | |
| 5 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 5.11% | — | — | |
| 6 | VCYT | Veracyte INC | Stock-Other | 4.49% | — | — | |
| 7 | 2JQ | Gritstone Bio INC | Stock-Other | 2.96% | — | — | |
| 8 | OCUL | Ocular Therapeutix INC | Stock-Other | 2.65% | — | — | |
| 9 | OPHTEUR | Iveric Bio INC | Stock-Other | 1.26% | — | — | |
| 10 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 0.27% | — | — | |
| 11 | CLVSEUR | Clovis Oncology INC | Stock-Other | 0.10% | — | — | |
| 12 | ✓ | Second Sight Med Prods INC | Stock-Other | 0.08% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ADVMCHF | Adverum Biotechnologies INC | +2.1% | -0.91% | Trim |
| 2 | CBAYUSD | Cymabay Therapeutics INC | +0.1% | — | Unchanged |
| 3 | ✓ | Second Sight Med Prods INC | -0.1% | — | Unchanged |
| 4 | CLVSEUR | Clovis Oncology INC | -0.1% | — | Unchanged |
| 5 | OCUL | Ocular Therapeutix INC | -0.4% | — | Unchanged |
| 6 | 2JQ | Gritstone Bio INC | -2% | — | Unchanged |
| 7 | VCYT | Veracyte INC | -3.6% | — | Unchanged |
| 8 | CRSP | CRISPR Therapeutics AG | -4.4% | -0.54% | Trim |
| 9 | AKRO | Akero Therapeutics INC | -8.3% | -22.70% | Trim |
| 10 | ✓ | — | NEW | New buy | |
| 11 | CRNX | Crinetics Pharmaceuticals In | — | NEW | New buy |
| 12 | OPHTEUR | Iveric Bio INC | — | NEW | New buy |